Evidence map›Paper›PMID 30453567›Full record

ArticleCancers2018

Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells.

Marie Alexandra Albaret, Claudine Vermot-Desroches, Arnaud Paré, Jean-Xavier Roca-Martinez, Lucie Malet, Jad Esseily, Laetitia Gerossier, Johan Brière, Nathalie Pion, Virginie Marcel and 16 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 3 institutions in 1 country.

Marie Alexandra AlbaretUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. marie.albaret@lyon.unicancer.fr.ORCID 0000-0003-3374-5298
Claudine Vermot-DesrochesiDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. vermotdesroches.claudine@gmail.com.
Arnaud ParéUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. arnopare@gmail.com.
Jean-Xavier Roca-MartinezUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. jxroca@free.fr.
Lucie MaletUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Lucie.MALET@lyon.unicancer.fr.
Jad EsseilyUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. jad_esseily@yahoo.com.
Laetitia GerossierUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. laetitia.gerossier@wanadoo.fr.
Johan BrièreUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. briere.johan@gmail.com.
Nathalie PionUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Nathalie.PION@lyon.unicancer.fr.
Virginie MarcelUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Virginie.MARCEL@lyon.unicancer.fr.ORCID 0000-0002-9557-8221
Frédéric CatezUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. frederic.catez@lyon.unicancer.fr.ORCID 0000-0001-8255-9091
Geneviève De SouzaUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Genevieve.DESOUZA@lyon.unicancer.fr.
Boris VuillermoziDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. vuillermoz.boris@laposte.net.
Franck DoerflingeriDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. franck.doerflinger@gmail.com.
Emilie LavocatiDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. emilie.lavocat@hotmail.fr.
Olivier SubigeriDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. Olivier_subiger@yahoo.fr.
Carine RoussetiDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. carine.rousset@gmail.com.
Corinne BressoniDD Biotech Bâtiment Accinov 317 avenue Jean Jaurès, 69007 Lyon, France. corinnebresson@hotmail.fr.
Elodie MandonCALIXAR Functional Membrane Proteins For Life, 60 avenue Rockefeller, 69008 Lyon, France. emandon@calixar.com.
Anass JawhariCALIXAR Functional Membrane Proteins For Life, 60 avenue Rockefeller, 69008 Lyon, France. ajawhari@calixar.com.
Pierre FalsonLaboratory of Molecular Microbiology and Structural Biochemistry, CNRS UMR 5086, IBCP, 69367 Lyon, France. pierre.falson@ibcp.fr.
Mélissa JasminUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. MelissaMarie.JASMIN@lyon.unicancer.fr.ORCID 0000-0002-3018-917X
Yohann CouteBiosciences and Biotechnology Institute of Grenoble-Laboratoire Biologie à Grande Echelle (BIG-BGE) U1038 INSERM/CEA/UGA, Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA) Grenoble, F-38054 Grenoble CEDEX 9, France. yohann.coute@cea.fr.ORCID 0000-0003-3896-6196
Hichem-Claude MertaniUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. hichem.mertani@lyon.unicancer.fr.
Pierre SaintignyUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. Pierre.SAINTIGNY@lyon.unicancer.fr.
Jean-Jacques DiazUniv Lyon, Université Claude Bernard Lyon 1, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69008 Lyon, France. jean-jacques.diaz@lyon.unicancer.fr.ORCID 0000-0002-7914-4319
Université Claude Bernard Lyon 1 · FRLaboratoire de Biologie Physico-Chimique des Protéines Membranaires · FRInserm · FR

Funding

ANR, SIRIC LYric Grant INCa and iDDbiotech INCa- DGOS-4664Proof of concept- CLARA Grant THERA8 project
6 · The paper itself

Abstract

Accumulating evidence supports the remarkable presence at the membrane surface of cancer cells of proteins, which are normally expressed in the intracellular compartment. Although these proteins, referred to as externalized proteins, represent a highly promising source of accessible and druggable targets for cancer therapy, the mechanisms via which they impact cancer biology remain largely unexplored. The aim of this study was to expose an externalized form of cytokeratin 8 (eK8) as a key player of colorectal tumorigenesis and characterize its mode of action. To achieve this, we generated a unique antagonist monoclonal antibody (D-A10 MAb) targeting an eight-amino-acid-long domain of eK8, which enabled us to ascertain the pro-tumoral activity of eK8 in both

Indexed as

bidirectional signalingexternalized keratin 8KRAS-mutant colorectal cancermonoclonal antibodytherapeutic target

Identifiers

PMID30453567
PMCPMC6266717
OpenAlexW2901650824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.